| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PPUL.1950040403 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fppul.1950040403 |
| https://onlinelibrary.wiley.com/doi/full/10.1002/ppul.1950040403 | ||
| P698 | PubMed publication ID | 3393383 |
| P2093 | author name string | J. C. Craft | |
| W. Waring | |||
| P. Black | |||
| J. Blumer | |||
| N. A. Halsey | |||
| J. M. McCarty | |||
| S. J. Tilden | |||
| P2860 | cites work | Pharmacokinetics of intravenously administered piperacillin in preadolescent children | Q34707899 |
| Piperacillin pharmacokinetics in pediatric patients | Q35716595 | ||
| Piperacillin: In Vitro Evaluation | Q36472026 | ||
| In Vitro Activity of Piperacillin Compared with That of Carbenicillin, Ticarcillin, Ampicillin, Cephalothin, and Cefamandole Against Pseudomonas aeruginosa and Enterobacteriaceae | Q39675313 | ||
| The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis | Q40299053 | ||
| Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosis | Q44324948 | ||
| Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? | Q44379999 | ||
| Adverse reactions to piperacillin in cystic fibrosis. | Q44952497 | ||
| Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo | Q54501407 | ||
| Piperacillin therapy for serious bacterial infections. | Q54549903 | ||
| Adverse reactions to piperacillin in patients with cystic fibrosis | Q55062344 | ||
| Adverse reactions to piperacillin in cystic fibrosis | Q72578215 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 201-204 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Pediatric Pulmonology | Q15749800 |
| P1476 | title | Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis | |
| P478 | volume | 4 |
| Q24201201 | Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis |
| Q24244685 | Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis |
| Q77222399 | Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis |
| Q24188313 | Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis |
| Q42202818 | Is there a role for antimicrobial stewardship in cystic fibrosis? |
| Q38040736 | Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins |
| Q38077518 | Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary |
| Q36439015 | Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children |
| Q92707799 | Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children |
| Q34824085 | Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis. |
| Q39025971 | Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis |
| Q24194967 | Single versus combination intravenous antibiotic therapy for people with cystic fibrosis |
| Q24244134 | Single versus combination intravenous antibiotic therapy for people with cystic fibrosis |
| Q34202477 | Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. |
| Q35878860 | Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers |
Search more.